Pathological, diagnostic, and therapeutic implications of non-coding RNAs in deep vein thrombosis: A comprehensive review.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Journal of Thrombosis and Thrombolysis

• Publication date

  2025-11-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11239-025-03202-2PMID 41222885
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The History and Historical Treatments of Deep-Vein Thrombosis: Towards the Era of New Anticoagulants.

  2025cited by this paper
• Anticoagulation Management: Current Landscape and Future Trends

  2025cited by this paper
• Acute phase determinant of post-thrombotic syndrome: A review of the literature.

  2024cited by this paper
• Advances in microRNA regulation of deep vein thrombosis through venous vascular endothelial cells (Review).

  2024cited by this paper
• Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease

  2024cited by this paper
• Transcription regulation by long non-coding RNAs: mechanisms and disease relevance

  2024cited by this paper
• High microRNA-145 plasma levels are associated with decreased risk of future incident venous thromboembolism - The HUNT study.

  2024cited by this paper
• Non-coding RNAs regulating endothelial progenitor cells for venous thrombosis: promising therapy and innovation

  2024cited by this paper
• Diagnostic and prognostic potential of long non-coding RNA NORAD in patients with acute deep vein thrombosis and its role in endothelial cell function

  2024cited by this paper
• MicroRNA-181b-5p/HEY2 axis is involved in the progress of deep venous thrombosis via mediating vascular endothelial injury

  2024cited by this paper
• Efficacy and safety of direct oral anticoagulants versus warfarin in the treatment of cerebral venous sinus thrombosis

  2024cited by this paper
• miR-483-5p-Containing exosomes treatment ameliorated deep vein thrombosis‑induced inflammatory response.

  2024cited by this paper
• Predictive value of prenatal ultrasound combined with long non-coding RNA CRNDE of women for their postpartum lower extremity deep venous thrombosis

  2024cited by this paper
• Roles of long noncoding RNAs in human inflammatory diseases

  2024cited by this paper
• Prediction model of deep vein thrombosis risk after lower extremity orthopedic surgery

  2024cited by this paper
• Downregulation of miR-125a-5p Promotes Endothelial Progenitor Cell Migration and Angiogenesis and Alleviates Deep Vein Thrombosis in Mice Via Upregulation of MCL-1

  2023cited by this paper
• Long Non-Coding RNAs: Bridging Cancer-Associated Thrombosis and Clinical Outcome of Ovarian Cancer Patients

  2023cited by this paper
• A systematic review and meta-analysis of risk prediction models for post-thrombotic syndrome in patients with deep vein thrombosis

  2023cited by this paper
• Non-coding RNAs in disease: from mechanisms to therapeutics

  2023cited by this paper
• Circ_0020123, a New Circular RNA Biomarker for Deep Vein Thrombosis in Pregnant Women.

  2023cited by this paper
• Association of Circulating Long Noncoding 7S RNA with Deep Vein Thrombosis

  2023cited by this paper
• Long Non-Coding RNAs in Venous Thromboembolism: Where Do We Stand?

  2023cited by this paper
• Long non-coding RNA-targeting therapeutics: discovery and development update

  2023cited by this paper
• LncRNA NEAT1 Promotes Vascular Endothelial Cell Dysfunction via miR-218-5p/GAB2 and Serves as a Diagnostic Biomarker for Deep Vein Thrombosis

  2023cited by this paper
• Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update

  2023cited by this paper
• Long non-coding RNA crnde promotes deep vein thrombosis by sequestering miR-181a-5p away from thrombogenic Pcyox1l

  2023cited by this paper
• microRNAs and Other Non-Coding RNAs as Targets for Anticancer Drug Development

  2023cited by this paper
• LINC00659 exacerbates endothelial progenitor cell dysfunction in deep vein thrombosis of the lower extremities by activating DNMT3A-mediated FGF1 promoter methylation

  2023cited by this paper
• Circular RNA in disease: Basic properties and biomedical relevance

  2022cited by this paper
• MSI1 Stabilizes MACF1 to Inhibit Apoptosis of MC3T3-E1 Cells Induced by High Glucose and Promote Osteogenic Differentiation Through Wnt/β-Catenin Signaling Pathway

  2022cited by this paper
• Knockdown of lncRNA XIST Ameliorates IL-1β-Induced Apoptosis of HUVECs and Change of Tissue Factor Level via miR-103a-3p/HMGB1 Axis in Deep Venous Thrombosis by Regulating the ROS/NF-κB Signaling Pathway

  2022cited by this paper
• MiR-199a target regulates TAB2 to promote the migration of endodermal progenitor cells and inhibit deep vein thrombosis in rats.

  2022cited by this paper
• The expanding world of noncoding RNA biology

  2022cited by this paper
• Long noncoding RNA TUG1 induces angiogenesis of endothelial progenitor cells and dissolution of deep vein thrombosis

  2022cited by this paper
• Depleted miR-125a-5p Causes Vascular Endothelial Cell Dysfunction in Deep Vein Thrombosis by Targeting Angiopoietin 2

  2022cited by this paper
• Significant role of long non-coding RNA MALAT1 in deep vein thrombosis via the regulation of vascular endothelial cell physiology through the microRNA-383-5p/BCL2L11 axis

  2022cited by this paper
• MicroRNA-26a confers a potential biomarker for screening of deep vein thrombosis

  2022cited by this paper
• Suppression of long intergenic non-protein coding RNA 1123 constrains lower extremity deep vein thrombosis via microRNA-125a-3p to target interleukin 1 receptor type 1

  2022cited by this paper
• MicroRNA-136-5p from Endothelial Progenitor Cells-released Extracellular Vesicles Mediates TXNIP to Promote the Dissolution of Deep Venous Thrombosis

  2022cited by this paper
• Combination of circulating miR-125a-5p, miR-223-3p and D-dimer as a novel biomarker for Deep Vein Thrombosis.

  2022cited by this paper
• Circular RNAs: Characterization, cellular roles, and applications.

  2022cited by this paper
• Pathophysiology of deep vein thrombosis

  2022cited by this paper
• Targeting non-coding RNAs to overcome cancer therapy resistance

  2022cited by this paper
• Upregulated miR-206 Aggravates Deep Vein Thrombosis by Regulating GJA1-Mediated Autophagy of Endothelial Progenitor Cells

  2022cited by this paper
• Hsa_circ_0001020 accelerates the lower extremity deep vein thrombosis via sponging miR-29c-3p to promote MDM2 expression.

  2022cited by this paper
• Study on the Effect and Mechanism of miR-185 on Lower Extremity Deep Venous Thrombosis

  2021cited by this paper
• LncRNA Sirt1-AS upregulates Sirt1 to attenuate aging related deep venous thrombosis

  2021cited by this paper
• Predictive value of miR-374a-5p of peripheral blood mononuclear cells in deep venous thrombosis for elderly patients after total hip arthroplasty.

  2021cited by this paper
• Up-regulated miR-204-5p promoted the migration, invasion, and angiogenesis of endothelial progenitor cells to enhance the thrombolysis of rats with deep venous thrombosis by targeting SPRED1.

  2021cited by this paper
• Microarray profile of circular RNAs identifies hsa_circ_000455 as a new circular RNA biomarker for deep vein thrombosis

  2021cited by this paper
• MiR-296-5p ameliorates deep venous thrombosis by inactivating S100A4

  2021cited by this paper
• Role and mechanism of mir-5189-3p in deep vein thrombosis of lower extremities: mir-5189-3p in deep vein thrombosis of lower extremities.

  2021cited by this paper
• MicroRNA-342-3p loaded by human umbilical cord mesenchymal stem cells-derived exosomes attenuates deep vein thrombosis by downregulating EDNRA

  2021cited by this paper
• Overexpression of MicroRNA-122 Resists Oxidative Stress-Induced Human Umbilical Vascular Endothelial Cell Injury by Inhibition of p53

  2020cited by this paper
• Downregulation of miR-103a-3p contributes to endothelial progenitor cell dysfunction in deep vein thrombosis through PTEN targeting.

  2020cited by this paper
• The Predictive Value of d-Dimer Test for Venous Thromboembolism During Puerperium: A Prospective Cohort Study

  2020cited by this paper
• LncRNA GUSBP5-AS promotes EPC migration and angiogenesis and deep vein thrombosis resolution by regulating FGF2 and MMP2/9 through the miR-223-3p/FOXO1/Akt pathway

  2020cited by this paper
• Reactive Oxygen Species in Venous Thrombosis

  2020cited by this paper
• Role of miR-92a-3p, oxidative stress, and p38MAPK/NF-κB pathway in rats with central venous catheter related thrombosis

  2020cited by this paper
• miR-374b-5p is increased in deep vein thrombosis and negatively targets IL-10.

  2020cited by this paper
• Long non-coding RNA MALAT1 suppresses the proliferation and migration of endothelial progenitor cells in deep vein thrombosis by regulating the Wnt/β-catenin pathway

  2020cited by this paper
• Downregulation of interleukin-6 and C-reactive protein underlies a novel inhibitory role of microRNA-136-5p in acute lower extremity deep vein thrombosis

  2020cited by this paper
• MiR-143-3p targets ATG2B to inhibit autophagy and promote endothelial progenitor cells tube formation in deep vein thrombosis.

  2020cited by this paper
• Overexpressed microRNA‐103a‐3p inhibits acute lower‐extremity deep venous thrombosis via inhibition of CXCL12

  2019cited by this paper
• Deep vein thrombosis: update on diagnosis and management

  2019cited by this paper
• Defect of SIRT1-FoxO3a axis is associated with the production of reactive oxygen species during protein kinase CK2 downregulation-mediated cellular senescence and nematode aging

  2019cited by this paper
• IL (Interleukin)-6 Contributes to Deep Vein Thrombosis and Is Negatively Regulated by miR-338-5p

  2019cited by this paper
• MiR‐205 promotes endothelial progenitor cell angiogenesis and deep vein thrombosis recanalization and resolution by targeting PTEN to regulate Akt/autophagy pathway and MMP2 expression

  2019cited by this paper
• miR-21 induces endothelial progenitor cells proliferation and angiogenesis via targeting FASLG and is a potential prognostic marker in deep venous thrombosis

  2019cited by this paper
• Elevated miR-195-5p expression in deep vein thrombosis and mechanism of action in the regulation of vascular endothelial cell physiology

  2019cited by this paper
• Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation

  2018cited by this paper
• A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.

  2018cited by this paper
• Endothelial Dysfunction and Venous Thrombosis

  2018cited by this paper
• Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians

  2017cited by this paper
• Integrating microRNA and messenger RNA expression profiles in a rat model of deep vein thrombosis

  2017cited by this paper
• Inferior vena cava filters

  2017cited by this paper
• Activation of NLRP3 inflammasome complex potentiates venous thrombosis in response to hypoxia

  2017cited by this paper
• Deep vein thrombosis: pathogenesis, diagnosis, and medical management.

  2017cited by this paper
• Non-coding RNA networks in cancer

  2017cited by this paper
• Role of microRNA-26a in the diagnosis of lower extremity deep vein thrombosis in patients with bone trauma.

  2017cited by this paper
• Guidance for the prevention and treatment of the post-thrombotic syndrome

  2016cited by this paper
• mTORC1 promotes aging-related venous thrombosis in mice via elevation of platelet volume and activation.

  2016cited by this paper
• Downregulation of let-7e-5p contributes to endothelial progenitor cell dysfunction in deep vein thrombosis via targeting FASLG.

  2016cited by this paper
• Upregulation of miR-483-3p contributes to endothelial progenitor cells dysfunction in deep vein thrombosis patients via SRF

  2016cited by this paper
• Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis

  2016cited by this paper
• Diagnostic potential of plasma microRNA signatures in patients with deep-vein thrombosis

  2016cited by this paper
• Endothelial progenitor cells accelerate the resolution of deep vein thrombosis.

  2016cited by this paper
• Deep vein thrombosis is accurately predicted by comprehensive analysis of the levels of microRNA-96 and plasma D-dimer.

  2016cited by this paper
• BCL2L11/Bim as a dual-agent regulating autophagy and apoptosis in drug resistance

  2015cited by this paper
• The Landscape of long noncoding RNA classification.

  2015cited by this paper
• Upregulation of MicroRNA‐126 Contributes to Endothelial Progenitor Cell Function in Deep Vein Thrombosis via Its Target PIK3R2

  2015cited by this paper
• Unique features of long non-coding RNA biogenesis and function

  2015cited by this paper
• A panel of microRNAs as a new biomarkers for the detection of deep vein thrombosis

  2015cited by this paper
• FOXO1-Mediated Activation of Akt Plays a Critical Role in Vascular Homeostasis

  2014cited by this paper
• Roles of the Oxidative Stress and ADMA in the Development of Deep Venous Thrombosis

  2014cited by this paper
• Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism.

  2014cited by this paper
• BCL2L11/BIM

  2013cited by this paper
• The long and short of microRNA.

  2013cited by this paper
• Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation

  2012cited by this paper
• Deep vein thrombosis: a clinical review

  2011cited by this paper

• MicroRNAs as potential biomarkers and future therapeutic targets in thrombosis: from molecular mechanisms to clinical implications.

  2026cites this paper